Clinical Trials

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM

Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Reliability and Validity of the Turkish Version of the PedHAL

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia